Vilin Bio Med Limited — Important, 16-04-2025: General Updates

Vilin Bio Med Ltd. has initiated an Open Offer for up to 36,27,000 fully paid equity shares, representing 26% of its voting share capital, at an Offer Price of ₹23.40 per share. This move follows a Share Purchase Agreement (SPA) involving the acquisition of 84,57,200 shares from selling shareholders, priced at ₹20.30 per share, amounting to a total consideration of approximately ₹17.17 crore (cr). The revised Offer Price results from reflecting additional shares acquired by the acquirers, which were omitted from the initial assessment.

The Offer, backed by an escrow amount totaling over ₹2.12 crore (cr), aims to consolidate control over the Company, enhancing the Acquirers' ownership and facilitating operations through active management. Public shareholders are encouraged to participate, but certain regulatory approvals may influence the Offer's execution and could result in withdrawal if not obtained. Overall, the Open Offer presents potential upside for both current and prospective shareholders, given the strategic implications for Vilin Bio Med. Investors should monitor developments closely.